IFNG and bacterial sexually transmitted disease: The experiments reported here demonstrate that the effect of i.vag.-administered IL-12/ms on immunity to gonococcal infection persisted for at least 6 months, that it extended to antigenically different, heterologous strains of N. gonorrhoeae, and that it depended upon both IFN-γ and B cells.